Clinical Trials

Breast Neoplasms

NCT04215731 2026-03-03

FOBEAR

582 enrolled

Rectal Neoplasms

NCT06107920 2026-02-10

COnCERTO

232 enrolled

Colonic Neoplasms

NCT04495088 2026-02-02

Preoperative FOLFOX Versus Postoperative Risk-adapted Chemotherapy in Patients With Locally Advanced Rectal Cancer

550 enrolled

Rectal Neoplasms

NCT07081360 2025-08-29

Neoadjuvant vs Upfront Surgery for Resectable Pancreatic Cancer and Periampullary Cancer

262 enrolled

Pancreatic Neoplasms

NCT06734702 2025-07-24

Neoadjuvant Immunotherapy Plus Chemotherapy Followed by Concurrent Chemoradiotherapy and Consolidative Immunotherapy for Locally Advanced Non-small Cell Lung Cancer

497 enrolled

Thoracic

Neoadjuvant Therapy

NCT01815853 2025-07-03

Neo-CRAG

620 enrolled

Stomach Neoplasms

NCT06235203 2025-06-03

Neoadjuvant vs Adjuvant in Locally Advanced Recurrent NPC

154 enrolled

Phase 3 Not yet recruiting

Nasopharyngeal Carcinoma

NCT06980545 2025-05-20

Total Neoadjuvant 6 Cycles of Chemotherapy Versus 3 Cycles in Partial Responder Patients Diagnosed With Epithelial Ovarian Cancer

50 enrolled

Stage III and IV Ovarian Cancer

NCT06977893 2025-05-18

Neoadjuvant Chemotherapy in Combination With Toripalimab for HR+/HER2- Breast Cancer : a Randomized, Open-label, Parallel-controlled, Multi-center Phase III Study (NEOTORCH-BREAST04)

194 enrolled

Phase 3 Not yet recruiting

Breast Neoplasms

NCT06957938 2025-05-08

Comparing Neoadjuvant Chemotherapy Combined With PD-1 Inhibitor Versus Neoadjuvant Chemotherapy in Locally Advanced Laryngeal and Hypopharyngeal Carcinoma

168 enrolled

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Hypopharyngeal Neoplasms, Laryngeal Neoplasms

NCT06712420 2025-04-16

NEOGB

114 enrolled

Gallbladder Neoplasms

NCT04460352 2025-03-06

NEEDS

1,020 enrolled

Esophageal Squamous Cell Carcinoma

NCT06775652 2025-01-15

ESCC

254 enrolled

Esophageal Squamous Cell Carcinoma

NCT05582265 2024-05-17

Tislelizumab Combined With Chemotherapy Followed by Surgery Versus Up-front Surgery in Resectable Head and Neck Squamous Cell Carcinoma (REDUCTION-I)

537 enrolled

Phase 3 Active not recruiting

Squamous Cell Carcinoma of Head and Neck

NCT02509286 2024-05-08

ESOPEC

438 enrolled

Adenocarcinoma Of Esophagus, Adenocarcinoma, Esophageal Neoplasms

NCT05173272 2023-12-27

Induction Chemotherapy Combined With Immunotherapy Followed by Concurrent Chemoradiation in Advanced Cervical Cancer

286 enrolled

Phase 3 Not yet recruiting

Uterine Cervical Neoplasms

NCT06097416 2023-10-25

Neoadjuvant Chemoradiotherapy Versus Total Neoadjuvant Therapy in the Treatment of T3 Rectal Cancer

100 enrolled

Rectal Neoplasms

NCT01606098 2023-09-13

CAIRO4

206 enrolled

Colonic Neoplasms, Rectal Neoplasms

NCT05984485 2023-08-09

TaLaR-02

766 enrolled

Rectal Neoplasms

NCT00664456 2023-07-24

SHIP0804

421 enrolled

Genitourinary

Prostatic Neoplasms

NCT05861505 2023-05-17

COLLISION RELAPSE Trial

360 enrolled

Recurrence, Colorectal Neoplasms

NCT05772208 2023-03-16

Intensified Treatments for Patients With Locally Advanced Nasopharyngeal Carcinoma With Detectable EBV DNA After One Cycle GP Regime Neoadjuvant Chemotherapy

459 enrolled

Nasopharyngeal Carcinoma

NCT00913705 2022-06-13

NATCH

624 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT04807673 2022-06-01

KEYSTONE-002

342 enrolled

Esophageal Squamous Cell Carcinoma

NCT05384366 2022-05-20

Neoadjuvant Chemotherapy in Cervical Cancer

33 enrolled

Uterine Cervical Neoplasms, Neoplasms

NCT03366415 2022-03-04

Sequential or Concurrent Chemoradiotherapy in Patients With Locoregionally Advanced NPC

420 enrolled

Nasopharyngeal Carcinoma

NCT03417622 2021-02-25

Wide Margin vs. Narrow Margin in Postneoadjuvant Lumpectomy

370 enrolled

Margins of Excision, Breast Neoplasms

NCT00002883 2021-02-23

Surgery With or Without Combination Chemotherapy in Treating Patients With Cancer of the Esophagus

250 enrolled

Adenocarcinoma Of Esophagus, Esophageal Neoplasms, Stomach Neoplasms

NCT00003652 2021-02-17

Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage II or Stage III Anal Cancer

350 enrolled

Anal Canal Carcinoma, Anus Neoplasms

NCT00227747 2021-02-17

Radiation Therapy and Capecitabine With or Without Oxaliplatin in Treating Patients Who Are Undergoing Surgery for Stage II or Stage III Rectal Cancer

598 enrolled

Rectal Neoplasms, Colorectal Neoplasms

NCT02175212 2020-11-20

AADLPC

362 enrolled 17 charts

Genitourinary

Prostate Adenocarcinoma

NCT01107639 2020-10-20

Radiation Therapy and Chemotherapy, With or Without Cetuximab, Followed by Surgery in Treating Patients With Locally Advanced Esophageal Cancer That Can Be Removed by Surgery

297 enrolled

Adenocarcinoma Of Esophagus, Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms

NCT01461850 2020-10-14

SCORPION

171 enrolled

Ovarian Neoplasms

NCT04370925 2020-06-16

Efficacy of HIPEC in Patients With Colorectal Cancer at High Risk of Peritoneal Carcinomatosis

GastrointestinalGynecologic

688 enrolled

Peritoneal Neoplasms, Colorectal Neoplasms

NCT00047112 2020-03-30

Surgery With or Without Radiation Therapy and Chemotherapy in Treating Patients With Esophageal Cancer

195 enrolled

Adenocarcinoma Of Esophagus, Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms

NCT02532400 2020-03-11

COMPETE

21 enrolled

Breast Neoplasms

NCT01314027 2019-07-25

Adjuvant Versus Neoadjuvant Plus Adjuvant Chemotherapy in Resectable Pancreatic Cancer

38 enrolled

Pancreatic Neoplasms

NCT01104571 2018-09-17

EPHOS-B

257 enrolled

Breast Neoplasms

NCT01554852 2018-06-11

Myeloma XI

4,420 enrolled

Plasma cell

Multiple Myeloma, Neoplasms, Plasma Cell

NCT03180177 2018-01-24

EHNPCTASEOC

263 enrolled

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms

NCT02858258 2017-12-19

ASCT After a Rituximab/Ibrutinib/Ara-c Containing iNduction in Generalized Mantle Cell Lymphoma

870 enrolled

Lymphoid

Lymphoma, Mantle-Cell

NCT00574080 2017-11-20

UARK 2006-15: A Study of Tandem Transplants With or Without Bortezomib and Thalidomide

20 enrolled 7 charts

Plasma cell

Multiple Myeloma

NCT03179579 2017-06-07

Efficacy of HIPEC Combined With Systemic Chemotherapy and CRS on Peritoneal Metastases From Gastric Cancer

GastrointestinalGynecologic

88 enrolled

Peritoneal Neoplasms, Stomach Neoplasms

NCT02960061 2016-11-09

HIPEC

640 enrolled

Stomach Neoplasms

NCT00190528 2016-09-22

A Trial of Neoadjuvant Chemotherapy + Surgery vs. Surgery for Bulky Stage I/II Cervical Cancer

200 enrolled

Uterine Cervical Neoplasms

NCT01521702 2015-03-20

NEOPAC

2 enrolled

Adenocarcinoma, Pancreatic Neoplasms

NCT02240524 2014-09-15

HIPEC

582 enrolled

Advanced Gastric Adenocarcinoma

NCT00705627 2014-05-28

A Multicenter Trial Comparing Multi-course Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma

400 enrolled